Wealth Alliance Advisory Group LLC cut its position in shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) by 2.9% in the second quarter, Holdings Channel.com reports. The firm owned 6,753 shares of the pharmacy operator’s stock after selling 200 shares during the quarter. Wealth Alliance Advisory Group LLC’s holdings in Walgreens Boots Alliance were worth $377,000 at the end of the most recent quarter.
Other hedge funds have also recently added to or reduced their stakes in the company. Comerica Securities Inc. raised its position in Walgreens Boots Alliance by 23.7% during the 4th quarter. Comerica Securities Inc. now owns 16,457 shares of the pharmacy operator’s stock worth $1,124,000 after purchasing an additional 3,154 shares during the last quarter. Dimensional Fund Advisors LP raised its position in shares of Walgreens Boots Alliance by 5.7% in the 4th quarter. Dimensional Fund Advisors LP now owns 7,374,621 shares of the pharmacy operator’s stock worth $503,913,000 after acquiring an additional 395,620 shares in the last quarter. Geode Capital Management LLC raised its position in shares of Walgreens Boots Alliance by 7.8% in the 4th quarter. Geode Capital Management LLC now owns 11,529,136 shares of the pharmacy operator’s stock worth $786,522,000 after acquiring an additional 834,241 shares in the last quarter. Hancock Whitney Corp bought a new position in shares of Walgreens Boots Alliance in the 4th quarter worth about $504,000. Finally, Cetera Advisors LLC raised its position in shares of Walgreens Boots Alliance by 29.4% in the 4th quarter. Cetera Advisors LLC now owns 18,870 shares of the pharmacy operator’s stock worth $1,288,000 after acquiring an additional 4,286 shares in the last quarter. 62.16% of the stock is owned by hedge funds and other institutional investors.
In related news, CAO Marco Patrick Anthony Pagni sold 20,000 shares of the company’s stock in a transaction on Thursday, May 9th. The shares were sold at an average price of $53.05, for a total value of $1,061,000.00. Following the completion of the transaction, the chief accounting officer now directly owns 435,811 shares in the company, valued at $23,119,773.55. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. 15.73% of the stock is currently owned by insiders.
Several research analysts have recently weighed in on WBA shares. Citigroup lifted their price objective on J2 Global from $86.00 to $95.00 and gave the stock a “neutral” rating in a research report on Wednesday, April 3rd. ValuEngine lowered WideOpenWest from a “hold” rating to a “sell” rating in a research report on Friday, June 28th. Cowen reaffirmed a “buy” rating and issued a $77.00 target price on shares of Centene in a research report on Sunday, March 31st. BidaskClub lowered Walgreens Boots Alliance from a “sell” rating to a “strong sell” rating in a research report on Monday, June 24th. Finally, Wells Fargo & Co upped their price objective on Exxon Mobil from $76.00 to $80.00 and gave the company a “market perform” rating in a research note on Wednesday, April 3rd. Six analysts have rated the stock with a sell rating, ten have issued a hold rating and four have assigned a buy rating to the company. Walgreens Boots Alliance has a consensus rating of “Hold” and an average price target of $63.82.
NASDAQ:WBA traded up $0.16 during midday trading on Friday, hitting $54.92. The company had a trading volume of 149,552 shares, compared to its average volume of 4,893,921. Walgreens Boots Alliance Inc has a 52-week low of $49.31 and a 52-week high of $86.31. The stock has a fifty day simple moving average of $53.93. The firm has a market cap of $49.85 billion, a P/E ratio of 9.12, a PEG ratio of 1.38 and a beta of 0.82. The company has a debt-to-equity ratio of 0.49, a current ratio of 0.76 and a quick ratio of 0.37.
Walgreens Boots Alliance (NASDAQ:WBA) last announced its earnings results on Thursday, June 27th. The pharmacy operator reported $1.47 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.42 by $0.05. Walgreens Boots Alliance had a net margin of 3.53% and a return on equity of 22.08%. The company had revenue of $34.59 billion during the quarter, compared to analyst estimates of $34.52 billion. During the same period in the previous year, the business earned $1.53 earnings per share. The firm’s quarterly revenue was up .7% compared to the same quarter last year. On average, sell-side analysts predict that Walgreens Boots Alliance Inc will post 5.98 earnings per share for the current year.
The business also recently announced a quarterly dividend, which will be paid on Thursday, September 12th. Investors of record on Tuesday, August 20th will be given a $0.458 dividend. The ex-dividend date is Monday, August 19th. This is a positive change from Walgreens Boots Alliance’s previous quarterly dividend of $0.44. This represents a $1.83 annualized dividend and a yield of 3.34%. Walgreens Boots Alliance’s payout ratio is 29.24%.
Walgreens Boots Alliance Company Profile
Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.
Read More: Coverage Ratio
Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.